← FDA Drug Approvals (Drugs@FDA)
NIACIN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HIBROW HLTHCARE · Approved 2023-08-25
Drug application
- FDA Application #
ANDA213090- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- NIACIN
- Generic name
- Niacin
- Active ingredients
- NIACIN
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- HIBROW HLTHCARE
- First approval
- 2023-08-25
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown